Raras
Buscar doenças, sintomas, genes...
Carcinoma tímico
ORPHA:99868CID-10 · C37CID-11 · 2C27.0DOENÇA RARA

O carcinoma tímico (CT) é um tipo de neoplasia epitelial tímica caracterizada por alto potencial maligno.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

O carcinoma tímico (CT) é um tipo de neoplasia epitelial tímica caracterizada por alto potencial maligno.

Pesquisas ativas
22 ensaios
77 total registrados no ClinicalTrials.gov
Publicações científicas
1.947 artigos
Último publicado: 2026 Mar 31

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adult
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: C37
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫁
Pulmão
2 sintomas
💪
Músculos
1 sintomas
🩸
Sangue
1 sintomas
📏
Crescimento
1 sintomas

+ 8 sintomas em outras categorias

Características mais comuns

90%prev.
Linfadenopatia mediastinal
Muito frequente (99-80%)
90%prev.
Neoplasia do timo
Muito frequente (99-80%)
55%prev.
Dispneia
Frequente (79-30%)
55%prev.
Edema palpebral
Frequente (79-30%)
55%prev.
Morfologia anormal da veia cava
Frequente (79-30%)
55%prev.
Paralisia diafragmática
Frequente (79-30%)
13sintomas
Muito frequente (2)
Frequente (7)
Ocasional (4)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 13 características clínicas mais associadas, ordenadas por frequência.

Linfadenopatia mediastinalMediastinal lymphadenopathy
Muito frequente (99-80%)90%
Neoplasia do timoNeoplasm of the thymus
Muito frequente (99-80%)90%
DispneiaDyspnea
Frequente (79-30%)55%
Edema palpebralPalpebral edema
Frequente (79-30%)55%
Morfologia anormal da veia cavaAbnormal vena cava morphology
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.947PubMed
Últimos 10 anos200publicações
Pico2025122 papers
Linha do tempo
2026Hoje · 2026🧪 1998Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 33
2Fase 210
1Fase 13
·Pré-clínico4
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Carcinoma tímico

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

14 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

77 ensaios clínicos encontrados, 22 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
1.182 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.182

#1

An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins.

JAMA network open2026 Mar 02

Distinguishing primary lung squamous cell carcinoma (SCC) from squamous metastases to the lung is a clinical challenge due to histopathologic similarities. Accurate diagnosis is essential to guide treatment decisions. To assess the utility of an artificial intelligence (AI) approach that includes evaluation of key orthogonal evidence in distinguishing primary lung SCCs from metastatic tumors of other tissue origins. This cross-sectional study used GPSai, a tissue-of-origin AI model run automatically on each sample submitted for molecular profiling, to flag potential misdiagnoses among research-eligible cases submitted as lung SCC. Molecularly profiled cases within the Caris Life Sciences clinicogenomic database from January 1, 2024, to January 31, 2025, were queried. All cases were reviewed by board-certified pathologists. The primary outcome was the rate of misdiagnosis among presumed lung SCCs confirmed by pathologist review and orthogonal evidence, which included clinical history and clinical findings, GATA3 and uroplakin II immunohistochemistry for urothelial carcinoma, UV variant signature for cutaneous SCC, CD5 and CD117 (c-KIT) immunohistochemistry for thymic carcinoma, and human papillomavirus positivity for orogenital SCC (eg, head and neck, cervical). Through a combination of AI and orthogonal evidence, 123 (3.1%) misdiagnoses were confirmed among 3958 cases submitted as presumed lung SCC (patients misdiagnosed: median [range] age, 71 [39 to >89]; 76.4% male). The cohort included 50 cutaneous SCCs (40.7%), 33 orogenital SCCs (26.8%) (including 25 head and neck [75.8%]), 20 urothelial carcinomas (16.3%), 15 thymic carcinomas (12.2%), 4 NUT carcinomas (3.3%), and 1 prostate SCC (0.8%). Ninety-two of the 123 patients (74.8%) had clinical history or findings consistent with the new diagnosis. Eighty-eight cases (71.5%) had differences in guideline-preferred first-line systemic therapies following the diagnosis change. In this cross-sectional study of patients diagnosed with lung SCC, a meaningful number of patients experienced misdiagnosis, which was identified using a multipronged AI-assisted approach. Diagnosis changes prompted by AI and orthogonal evidence may assist clinicians in prognostication and therapy selection.

#2

Neuro-ophthalmic presentation of leptomeningeal metastasis of thymoma: a case report.

Frontiers in neurology2026

Leptomeningeal disease (LMD) of the brain and spinal cord can present with visual loss or diplopia. Although LMD can occur in many forms of neoplasia, thymoma-related LMD is exceedingly rare. A 53-year-old Hispanic male with a history of chest pain, weight loss, and night sweats was diagnosed with stage 4 thymoma with lung and pleural metastasis. He received chemotherapy for metastatic thymoma. Few months later, patient presented with severe right-sided facial pain and lip numbness, ptosis and double vision. The patient was diagnosed with multiple cranial and spinal nerve involvement due to thymomatous LMD, confirmed on magnetic resonance imaging and lumbar puncture. LMD is a rare presentation of a malignant thymoma. Current guidelines for thymoma management emphasize the importance of staging imaging to rule out distant metastasis. Our case highlights the importance of a head-to-mid-thigh positron emission tomography (PET) scan in patients with known metastatic thymomas, with multiple PET scans, if possible, at regular intervals, owing to the aggressive nature of metastatic thymomas. Clinicians should be aware of the neoplastic (e.g., metastatic disease and LMD) and paraneoplastic (e.g., thymoma-related myasthenia gravis) neuro-ophthalmic presentations of thymoma.

#3

Thymic carcinoma presenting with cardiac tamponade and superior vena cava invasion.

BMJ case reports2026 Jan 06

We present the case of a woman in her 40s who presented with progressive shortness of breath, facial flushing, tachycardia that worsened when supine and bilateral leg swelling. Initial evaluation included a chest X-ray, which revealed widened mediastinum and a transthoracic echocardiogram with evidence of cardiac tamponade. A pericardiocentesis was performed, draining 900 mL of haemorrhagic fluid. Subsequent CT imaging identified a large anterior mediastinal mass invading into the superior vena cava (SVC) and extending towards the right atrium. A needle biopsy confirmed the diagnosis of thymic carcinoma. The patient remained stable and was started on chemotherapy. This case highlights the importance of considering SVC invasion in patients presenting with cardiac tamponade and mediastinal masses, particularly when positional symptoms such as orthostatic tachycardia and facial flushing are present.

#4

Transforming Growth Factor-β1 as a Biomarker of Malignant Behavior and PD-L1 Expression in Thymic Epithelial Tumors.

Cancer science2026 Jan

The clinical significance and molecular mechanisms underlying tumor progression in thymic epithelial tumors (TETs) remain largely unclear. In this retrospective single-center study, we evaluated the prognostic value of transforming growth factor-beta 1 (TGF-β1) and its relationship with programmed death-ligand 1 (PD-L1) expression. A total of 92 patients with surgically resected TETs, including 79 thymomas and 13 thymic carcinomas, were included. Immunohistochemical analyses were performed to assess the expression of TGF-β1, PD-L1, phosphorylated Smad2 (pSmad2), and pSmad3. Associations between TGF-β1 expression and clinicopathological features were analyzed, and mechanistic interactions were investigated using two thymic carcinoma cell lines exposed to exogenous TGF-β1. High TGF-β1 expression was observed in 28% of patients and was significantly associated with advanced Masaoka stage (III/IV), shorter tumor doubling time (median 328 vs. 713 days, p = 0.042), and lower 5-year freedom from recurrence (FFR) rates (58.1% vs. 95.1%, p < 0.001, log-rank test). Coexpression of high TGF-β1 and PD-L1 was linked to the poorest prognosis (5-year FFR: 46.1%) and was identified as an independent predictor of recurrence (adjusted hazard ratio: 7.15; 95% confidence interval: 1.20-42.8). Immunohistochemically, TGF-β1 expression positively correlated with PD-L1 and pSmad2/3 expression. In vitro, TGF-β1 stimulation upregulated PD-L1 expression in a dose-dependent manner, accompanied by increased pSmad2/3 activation. These findings indicate that high TGF-β1 expression demarcates a biologically aggressive TET phenotype and, together with PD-L1, refines postoperative risk stratification, while its ability to drive PD-L1 via Smad signaling could support the blockade of these pathways as a potential therapeutic strategy.

#5

Case Report of a Rare Pediatric B2 Thymoma With Focal Thymic Carcinoma Foci and Bone Marrow Metastasis.

Pediatric blood &amp; cancer2026 Mar 24

Publicações recentes

Ver todas no PubMed

📚 EuropePMC921 artigos no totalmostrando 198

2026

Case Report of a Rare Pediatric B2 Thymoma With Focal Thymic Carcinoma Foci and Bone Marrow Metastasis.

Pediatric blood &amp; cancer
2026

Long-Term Outcomes of Surgery for Thymic Epithelial Tumors With Pleural Metastases.

JTO clinical and research reports
2026

An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins.

JAMA network open
2026

Brief Report: Androgen Receptor Expression Is Associated With Male Predominance in Thymic Neuroendocrine Neoplasms.

JTO clinical and research reports
2026

Thymic epithelial tumors at the crossroads of immunity, autoimmunity, and immunotherapy.

Cancer immunology, immunotherapy : CII
2026

Genomic landscape and subgroup stratification of thymic epithelial tumors: a systematic meta-analysis of next-generation sequencing data.

Frontiers in oncology
2026

Case Report: Complete remission of thymic carcinoma using dose-dense chemotherapy.

Frontiers in oncology
2025

Advanced thymic carcinoma with suspected cardiac metastasis: multimodal diagnostic precision using CT, PET-CT, and immunohistochemistry.

The Pan African medical journal
2026

Potential Biomarkers in Thymic Epithelial Tumors: Thymoma and Thymic Carcinoma.

Journal of the National Comprehensive Cancer Network : JNCCN
2026

Neuro-ophthalmic presentation of leptomeningeal metastasis of thymoma: a case report.

Frontiers in neurology
2026

Noninvasive biomarkers in thymic epithelial tumors: a systematic review of cfDNA/ctDNA detection, molecular profiling, and organoid-based monitoring.

Journal of thoracic disease
2026

Somatic and germline genomic variation in thymic carcinomas.

ESMO open
2026

[Clinicopathological and molecular genetic features of micronodular thymic neoplasms with lymphoid stroma: a study of seventeen cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2026

Mucoepidermoid carcinoma of the thymus: a case report and review of literature.

Journal of cardiothoracic surgery
2026

Advanced Thymic Carcinoma Responds to Venetoclax and Azacitidine.

Clinical lung cancer
2026

Subtype-Dependent Expression Patterns of Core Hippo Pathway Components in Thymic Epithelial Tumors (TETs): An RT-qPCR Study.

Biomedicines
2026

Exosome-Transferred STAT3 from Cancer-Associated Fibroblasts Expedites Thymic Carcinoma Malignant Progression and M2 Macrophage Polarization Through Transcriptionally Activating KLHL5.

Applied biochemistry and biotechnology
2026

Biomimetic 3D-Bioprinted organoids of thymic epithelial tumors for translational drug screening and biomarker identification.

Materials today. Bio
2026

Impact of relative dose intensity of first-line platinum-based chemotherapy in patients with thymic epithelial tumors: a retrospective study.

Therapeutic advances in medical oncology
2026

Characterization of tumour microenvironment in thymic epithelial tumours of different histological subtypes.

Discover oncology
2026

Recurrent microsatellite instability-high thymic carcinoma showing complete response to immune checkpoint inhibitor: A case report.

Oncology letters
2026

Efficacy and safety of first-line lenvatinib in patients with advanced or recurrent thymic carcinoma in the real-world setting.

Lung cancer (Amsterdam, Netherlands)
2026

Salvage Surgery Following Definitive Chemoradiotherapy and Immune Checkpoint Inhibitor Therapy for Locally Advanced Thymic Carcinoma.

Interdisciplinary cardiovascular and thoracic surgery
2026

Percutaneous suspension technique for thymectomy and superior vena cava replacement without sternotomy in a patient with thymic carcinoma: Case report.

JTCVS techniques
2026

Non-mucinous, enteric-type thymic adenocarcinoma: genetic analysis of a case.

General thoracic and cardiovascular surgery cases
2026

A clinically applicable and generalizable deep learning model for anterior mediastinal tumors in CT images across multiple institutions.

Scientific reports
2026

Genomic Landscape of Thymic Carcinoma: A Large-Scale Analysis of Somatic Mutations, Demographic Disparities, and Metastatic Drivers from the AACR Project GENIE® Cohort.

Current issues in molecular biology
2026

A case of thymic carcinoma harboring an FGFR3 S249C mutation with durable disease control on lenvatinib.

International cancer conference journal
2026

Immunohistochemical biomarker-associated radiomics for classifying thymic epithelial tumors: a multicenter retrospective study.

NPJ precision oncology
2025

Recurrent Thymic Carcinoma Manifesting as a Diaphragmatic Mass: A Rare Presentation.

Cureus
2026

Development of Nomogram for Predicting Postoperative Progression Risk in High-Risk Thymoma and Thymic Carcinoma Utilizing Clinical and Preoperative CT Features.

Clinical Medicine Insights. Oncology
2026

Thymic epithelial tumors in pediatric, adolescent, and young adult patients: A national cohort analysis of clinical characteristics, treatment patterns, and survival outcomes.

Journal of pediatric surgery
2025

Neoadjuvant Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy in Thymic Epithelial Tumors: A Propensity Score-Matched Analysis.

Cancers
2026

Serum Cytokeratin 19 Fragment Antigen 21-1 as a Diagnostic and Prognostic Biomarker for Thymic Carcinoma in Thymic Masses.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
2026

Long-term disease stabilization with lenvatinib in advanced thymic carcinoma: A case report.

Rare tumors
2026

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; imlunestrant for breast cancer, tafasitamab for follicular lymphoma, atezolizumab for thymic carcinoma, retifanlimab for anal canal squamous cell carcinoma, and tagraxofusp for blastic plasmacytoid dendritic cell neoplasm.

International journal of clinical oncology
2025

Managing stage IV thymic carcinoma-a narrative review of radiation therapy strategies and options.

Mediastinum (Hong Kong, China)
2026

Thymic carcinoma presenting with cardiac tamponade and superior vena cava invasion.

BMJ case reports
2025

Systemic immune-inflammation index prior to postoperative radiotherapy as a tool for outcome prediction in thymic epithelial tumors.

Radiation oncology journal
2025

Intrathyroidal thymic carcinoma comprising squamous cell and small cell carcinoma components: A case report.

World journal of clinical oncology
2025

Intrathyroidal thymic carcinoma initially suspected as a parathyroid tumor: a case report and literature review.

Frontiers in oncology
2025

Efficacy and safety of perioperative immunotherapy for locally advanced thymic squamous cell carcinoma: a retrospective pilot study.

Frontiers in surgery
2026

Impact of Combined Additional Resections on the Surgical Outcomes of Robot-Assisted Resection of Thymic Epithelial Tumors.

Journal of surgical oncology
2025

Somatic Mutations of Thymic Epithelial Tumors Identified in the Prospective THYMOGENE Trial.

Thoracic cancer
2026

Deep learning discriminates thymic epithelial tumors' histological subtypes using digital pathology.

Annals of oncology : official journal of the European Society for Medical Oncology
2025

The Risk of Cardiovascular Adverse Outcomes in Patients With Thymoma or Thymic Carcinoma Receiving Cancer Therapy.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
2025

Circulating innate lymphoid cells and IL-18 as potential immune biomarkers in thymic tumors.

Frontiers in immunology
2025

Proteasome inhibition as a potential therapeutic target in thymic cancer.

Cell death &amp; disease
2025

Preoperative Biopsy Is Not Associated With Overall Survival in Patients With Surgically Resected Localized Thymoma.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
2026

Galectin-7 as a biomarker for aggressiveness and poor prognosis in thymic epithelial tumors.

Translational oncology
2025

Isolated thymic metastasis of breast cancer 10.5 years after surgery: a case report.

General thoracic and cardiovascular surgery cases
2026

Intrathyroid thymic carcinoma diagnosed following an odontogenic infection: Insights from a rare clinical presentation.

Oral oncology
2025

Genetic Characteristics of Disease Flare After Lenvatinib Discontinuation in Patients With Thymic Carcinoma: A Brief Report.

JTO clinical and research reports
2025

Clinical imaging features and outcomes of intrathyroidal thymic carcinoma: an analysis of fourteen patients at a single medical institution.

Frontiers in oncology
2026

Long-Term Outcomes of Surgical Resection for Thymic Epithelial Tumour With Intrathoracic Dissemination.

Interdisciplinary cardiovascular and thoracic surgery
2025

Bilateral Phrenic Nerve Reconstruction With Intercostal Nerve Grafts After Thymic Carcinoma Resection.

The Annals of thoracic surgery
2025

The role of adjuvant chemotherapy in patients with thymoma and thymic carcinoma following surgery: a systematic literature review and meta-analysis.

Journal of thoracic disease
2025

Analysis of efficacy and safety of intensity-modulated radiotherapy with "Target-Ring" strategy for stage IVA large-volume thymoma and thymic carcinoma: a single-center study.

Journal of thoracic disease
2025

Robotic-assisted thymectomy for locally advanced thymic malignancy: technical refinement and oncologic outcomes from a 20-year cohort.

Journal of thoracic disease
2026

Transforming Growth Factor-β1 as a Biomarker of Malignant Behavior and PD-L1 Expression in Thymic Epithelial Tumors.

Cancer science
2026

A rare case of thymoma with extensive clear cell components: a discussion of its clear cell transformation.

Medical molecular morphology
2025

Precision Medicine in Thoracic Surgery: Chest Wall, Pleural, and Mediastinal Malignancies.

Thoracic surgery clinics
2025

Immune Checkpoint Therapy for Thymic Carcinoma.

Cancers
2025

Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 Trial.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
2025

Artificial intelligence for diagnosis and prognosis of thymic epithelial tumors: a systematic review.

Mediastinum (Hong Kong, China)
2025

Factors distinguishing thymomas from thymic squamous cell carcinoma: a proposal for diagnosis emphasizing the immunophenotype.

Mediastinum (Hong Kong, China)
2025

The Value of Baseline [18F]FDG-PET in Predicting the Progression-Free Survival in Patients with Thymic Epithelial Tumours: A Systematic Review and Meta-Analysis.

Diagnostics (Basel, Switzerland)
2026

Total thymectomy is oncologically superior to partial thymectomy in patients with thymic carcinoma: insights from a multicenter real-world data analysis.

International journal of surgery (London, England)
2025

Durable Response to Lenvatinib in Platinum-Refractory Metastatic High-Grade Thymic Mucoepidermoid Carcinoma: A Case Report.

JTO clinical and research reports
2025

Comparative analysis of the tumor immune microenvironment between thymoma and thymic carcinoma.

Lung cancer (Amsterdam, Netherlands)
2025

Chemoradiotherapy as a pivotal therapeutic modality for inoperable intrathymic thyroid carcinoma: A case report and literature review.

Medicine
2026

International Thymic Malignancy Interest Group Standard Definitions, Policies, and Reporting Measures for Thymic Epithelial Tumors.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
2025

Intrathyroidal Thymic Carcinoma With Arterial Invasion and Presumed Poor Tolerance to Cerebral Ischemia Safely Treated With Intraoperative Carotid Artery Protection With a Covered Stent: A Case Report.

Clinical case reports
2025

Association Between Human Papillomavirus and Thymic Cancer: A Population-Based Cohort Study.

Cancer management and research
2025

PERM associated with thymic carcinoma with triple-autoantibody positivity: case report and literature review.

Journal of neuroimmunology
2025

Incremental diagnostic value of tumor habitat radiomics for risk stratification in thymic epithelial tumors.

Frontiers in oncology
2025

Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine. 2024. Edited by the Japan Lung Cancer Society. Chapter 3 Guidelines for thymic epithelial tumors - Summary of recommendations.

Respiratory investigation
2025

Avelumab combined with axitinib for patients with advanced thymoma B3 and thymic carcinoma.

Cancer
2025

Results of radiotherapy for thymoma: retrospective cohort and propensity score matching analysis.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
2025

Cytoreductive surgery with radical pleurectomy/Decortication and intraoperative photodynamic therapy as a treatment for stage IVa and pleural recurrence thymic tumors.

Photodiagnosis and photodynamic therapy
2025

Intrathyroid thymic carcinoma of the left thyroid lobe: A case report and literature review.

Oral oncology
2025

Thymus-like phenotype in benign lymphoepithelial neoplasms of salivary glands: clinicopathological and molecular characterization and reappraisal of relationship to non-sebaceous lymphadenoma.

Virchows Archiv : an international journal of pathology
2025

Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial.

The Lancet. Oncology
2025

Unresectable Primary Enteric-Type Thymic Adenocarcinoma Treated With FOLFOX Chemotherapy: A Case Report.

Cancer reports (Hoboken, N.J.)
2026

Case Report and Literature Review: Intrathyroid Thymic Carcinoma.

Journal of clinical ultrasound : JCU
2026

Fascin-1 expression is associated with EMT and recurrence in thymic carcinoma: a clinicopathologic study.

Medical molecular morphology
2025

Preoperative Cytological Diagnosis of Intrathyroidal Thymic Carcinoma: A Case Report With Review of the Literature.

Diagnostic cytopathology
2025

Da Vinci Xi robot -assisted subxiphoid resection of thymoma and reconstruction of the left brachiocephalic vein: A case report.

International journal of surgery case reports
2025

[Thymic Lymphoepithelial Carcinoma:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery
2025

[Myasthenia Gravis Treated with Zilucoplan Prior to Extended Transsternal Thymectomy for the Prevention of Myasthenic Crisis: A Case Report].

Brain and nerve = Shinkei kenkyu no shinpo
2025

Complete remission of brain metastasis from thymic carcinoma following hypofractionated gamma knife radiosurgery: Case report and a review of literature.

International journal of surgery case reports
2025

Physician-guided deep learning model for assessing thymic epithelial tumor volume.

Journal of medical imaging (Bellingham, Wash.)
2025

Predictive role of tumor-infiltrating lymphocytes and immune phenotype for pembrolizumab in relapsed or refractory thymic carcinoma.

Journal of thoracic disease
2025

Recurrence Patterns, Treatment Outcomes, and Prognostic Factors of Thymic Carcinoma: A Multicenter Study.

Cancers
2025

Fine-Needle Aspiration Cytologic Diagnosis of Intrathyroidal Thymic Carcinoma: A Review of the Literature.

Diagnostic cytopathology
2025

Expression of INSM1 in salivary carcinoma showing thymus-like elements (CASTLE).

Annals of diagnostic pathology
2025

Successful treatment with pembrolizumab for microsatellite instability-high thymic carcinoma: A case report.

Respiratory medicine case reports
2025

Parallel Phase II Clinical Trials of Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma.

JTO clinical and research reports
2025

Efficacy and Safety of First-Line Anti-PD-1 Antibody Combined With Taxane-Platinum Versus Taxane-Platinum Alone in Metastatic Thymic Carcinoma: A Real-World Retrospective Study.

Clinical lung cancer
2026

Micronodular Thymic Carcinoma With Lymphoid Hyperplasia: A Case Report and Next Generation Sequencing Analysis With its Benign Counterpart Multinodular Thymoma With Lymphoid Stroma.

International journal of surgical pathology
2025

Complete pathologic response after concomitant pembrolizumab and radiotherapy in a patient with pretreated metastatic thymic carcinoma: a case report.

Mediastinum (Hong Kong, China)
2025

Narrative review of the prognostic significance of primary tumor size in thymic epithelial tumor.

Mediastinum (Hong Kong, China)
2025

Surveillance of thymic epithelial tumors (TETs)-a narrative review.

Mediastinum (Hong Kong, China)
2025

Histologic features, growth patterns and classification of atypical thymomas.

Mediastinum (Hong Kong, China)
2025

Surgical Expert Consensus on Clinical Management of Advanced Thymoma and Thymic Carcinoma: A Beijing-Tianjin-Hebei Collaborative Initiative.

Thoracic cancer
2025

PD-L1 expression on tumor cells and tumor-infiltrating immune cells in thymic epithelial tumors detected with SP142 and SP263 antibodies.

PloS one
2025

Pure red-cell aplasia after radioactive iodine treatment in a patient with papillary thyroid cancer and follow up for two years: a case report.

Frontiers in oncology
2025

An extremely rare case of thymic carcinoma manifesting as a liver metastasis: a case report and literature review.

Discover oncology
2025

Oncological outcomes of the first pulmonary artery trunk transplantation for thymic carcinoma: a reflective analysis of surgical radicality.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
2025

Altered levels of sphingomyelins, ceramides, glycerophospholipids, and diacylglycerols in thymoma tissues.

Biochimica et biophysica acta. Molecular and cell biology of lipids
2025

Clinical characteristics and outcomes of patients with intrathyroidal thymic carcinoma (ITC): a retrospective cohort study.

Gland surgery
2025

Point of view: Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.

Med (New York, N.Y.)
2025

An update on the therapeutic options for metastatic thymomas and thymic carcinomas.

Expert review of anticancer therapy
2025

Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN
2025

Case Report: Robust and durable response to the combination of tislelizumab and chemotherapy in advanced thymic epithelial tumors: a case series.

Frontiers in immunology
2025

What Is Your Diagnosis: Mediastinal Mass in a Dog.

Veterinary clinical pathology
2025

A Case Series: Can a Cytological Smear Indicate the Histological Type of Thymoma and Distinguish Thymoma From Thymic Carcinoma?

Diagnostic cytopathology
2025

Lenvatinib for patients with previously treated advanced thymic carcinoma in real-world settings.

ESMO open
2025

Therapeutic Management of Metastatic Thymoma and Thymic Carcinoma.

Current oncology reports
2025

Recurrent Drug-Induced Pneumothorax Associated With Lenvatinib: A Case Report.

Respirology case reports
2025

Postoperative therapy patterns for thymic carcinoma with complete resection: retrospective analysis of 120 patients.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
2025

Enteric thymic adenocarcinoma: Understanding a unique pathology in the mediastinum.

Indian journal of pathology &amp; microbiology
2025

Rising Threat: Long-Term Trends in the Incidence and Mortality of Thymic Epithelial Tumor.

Cancer medicine
2025

Therapeutic management of patients with advanced thymic malignancies: A review for clinicians.

Lung cancer (Amsterdam, Netherlands)
2025

Serum Lenvatinib and Interleukin-6 Profiles and Their Relationship With Acute Heart Failure Development in a Patient With Thymic Carcinoma and Cancer Inflammation.

Therapeutic drug monitoring
2025

Screening of optimal candidates for postoperative radiotherapy among patients with resectable thymic tumors: a multicenter retrospective study.

Lung cancer (Amsterdam, Netherlands)
2025

Thymic tumors: radiotherapy experience for single institute.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
2025

Navigating the rare: a case report of intrathyroidal thymic carcinoma.

Gland surgery
2025

Thymic Carcinoma Invading Bilateral Internal Thoracic Artery Bypass Grafts: Diffuse Stenosis Suggesting Extravascular Compression.

JACC. Case reports
2025

Thymic Lymphoepithelial Carcinoma in Children: Report of Four Cases and Review of Literature.

Fetal and pediatric pathology
2025

CD5 Immunoreactivity Is Associated With Longer Overall Survival in Thymic Carcinoma: A Brief Report.

JTO clinical and research reports
2025

Yttrium-90 Radioembolization for Hepatic Metastases Secondary to Thymic Malignancies: A Case Report.

JTO clinical and research reports
2025

Evaluating therapeutic plasma exchange and protease inhibitors as mechanisms to reduce soluble mesothelin.

Scientific reports
2025

Is PET-CT able to predict histology and aggressiveness of thymic epithelial tumours?

Interdisciplinary cardiovascular and thoracic surgery
2025

Work-in-progress report: a prospective, multi-institutional observational study on intraoperative lymph node dissection for thymic epithelial malignancies with radiologically invasive features.

Mediastinum (Hong Kong, China)
2025

Tumour dimension is a prognostic factor in thymic epithelial tumours: An update analysis from the ESTS thymic database: Tumour dimension in thymic tumours.

Lung cancer (Amsterdam, Netherlands)
2025

Dosimetric superiority of deep inspiration breath hold-proton beam therapy for cardiac metastasis.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists
2025

Recurrence and Survival Following Robotic Resection of Thymomas Greater Than Five Centimeters.

Journal of surgical oncology
2025

Real-World Efficacy and Safety of Lenvatinib in Advanced or Recurrent Thymic Carcinoma: A Multicenter Retrospective Study in Japan.

Thoracic cancer
2025

An Innovative Management in the Diagnosis of Mediastinal Masses.

Thoracic cancer
2025

Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.

Med (New York, N.Y.)
2025

Predicting the risk grades of thymic epithelial tumours using T1 mapping and diffusion-weighted MRI.

The British journal of radiology
2025

Machine learning for predicting the prognosis of patients with thymoma and thymic carcinoma.

Journal of thoracic disease
2025

Clinical significance of positron emission tomography-computed tomography in the classification of thymic tumors.

Interdisciplinary cardiovascular and thoracic surgery
2025

Efficacy and safety of lenvatinib in a case of thymic carcinoma complicated with interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: A case report.

Respiratory medicine case reports
2025

Surgical Intervention Improves Long-Term Survival in Stage IV Thymic Epithelial Tumors: Insights From a SEER Database Analysis.

Thoracic cancer
2025

Evaluation of Innate Immune System, Body Habitus, and Sex on the Pharmacokinetics and Pharmacodynamics of Anetumab Ravtansine in Patients With Cancer.

Clinical and translational science
2025

Activity and safety of atezolizumab plus carboplatin and paclitaxel in patients with advanced or recurrent thymic carcinoma (MARBLE): a multicentre, single-arm, phase 2 trial.

The Lancet. Oncology
2025

Thymic carcinoma recurring 11 years post-extended surgery: a case report.

General thoracic and cardiovascular surgery cases
2025

First Report of Pembrolizumab Activity in KIT-Mutated Thymic Carcinoma.

Current oncology (Toronto, Ont.)
2025

Efficacy and Safety of Atezolizumab in Chinese Patients With Advanced Thymic Carcinoma: A Multicenter, Single-Arm Phase 2 Study.

Clinical lung cancer
2025

Advanced thymic epithelial tumour resection: vascular resection and reconstruction strategy.

Journal of thoracic disease
2025

Understanding the uncommon: Insights into thymoma associated immunodeficiency.

Asian Pacific journal of allergy and immunology
2025

Rapid growing mass of the mandible due to an oral metastasis of thymoma: Case report of an extremely rare localization and review of published cases.

Heliyon
2025

Diagnostic and prognostic relevance of inflammatory markers in surgically treated thymic epithelial tumors: An international multicenter study.

Lung cancer (Amsterdam, Netherlands)
2024

Effectiveness of Adjuvant Chemo- and Radiotherapy in Thymic Carcinoma Stage II: A Systematic Review and Meta-Analysis.

Cancer control : journal of the Moffitt Cancer Center
2025

Successful Radical Resection Of Masaoka Iii Squamous Cell Thymic Carcinoma Invading Superior Vena Cava And Right Atrium - Case Report.

Portuguese journal of cardiac thoracic and vascular surgery
2025

Cardiac Exposure Related to Adjuvant Radiotherapy in Patients Affected by Thymoma: A Dosimetric Comparison of Photon or Proton Intensity-Modulated Therapy.

Cancers
2025

The Rare Entity of Basaloid Thymic Carcinoma: A Multicentric Retrospective Analysis from the Italian Collaborative Group for ThYmic MalignanciEs (TYME).

Cancers
2025

Recurrent Thymic Carcinoma Treated With Median Sternotomy, Innominate Vein Replacement for Superior Vena Cava, and Iodide Implantation: A Case Report and Review of the Literature.

Cancer reports (Hoboken, N.J.)
2024

Long-term Survival in Stage IVb Thymic Carcinoma With Multidisciplinary Aggressive Treatment.

Annals of thoracic surgery short reports
2024

Current immunotherapy for thymic epithelial tumors: a narrative review.

Mediastinum (Hong Kong, China)
2025

Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic Carcinoma.

Clinical lung cancer
2025

Immunotherapy in thymic epithelial tumors: an attractive dilemma.

Investigational new drugs
2025

[Intrathyroid thymic carcinoma: report of a case].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery
2025

Prognostic Impact of Primary Tumor Size in Thymic Epithelial Tumor: An NCDB-Based Study.

Annals of surgical oncology
2024

Ultrasonographic and pathological findings of intrathyroidal thymic carcinoma.

Medical ultrasonography
2024

SNAI1 promotes epithelial-mesenchymal transition and maintains cancer stem cell-like properties in thymic epithelial tumors through the PIK3R2/p-EphA2 Axis.

Journal of experimental &amp; clinical cancer research : CR
2024

Choosing the proper path: outcomes of subxiphoid vs. lateral intercostal approaches in the resection of anterior mediastinal masses.

Frontiers in surgery
2024

Corrigendum: Case report: A sustained survival benefit of third-line immunotherapy for refractory thymic carcinoma.

Frontiers in oncology
2024

Long-term survival and prognosis after surgical treatment of patients with thymic carcinoma: a retrospective analysis.

Journal of thoracic disease
2024

[Thymic Carcinoma with Massive Pericardial Effusion:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery
2024

[Thymic Carcinoma Operated After Lung Cancer Operation:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery
2025

Serial positron-emission tomography after induction therapy as a predictor of prognostic outcomes for patients with thymic carcinoma.

Surgery today
2024

Key Therapeutic Agents for Thymic Carcinoma in Real-world Clinical Practice.

Anticancer research
2024

Surgical treatment of thymic epithelial tumor and myasthenia gravis.

Frontiers in surgery
2024

[Micronodular thymic carcinoma with lymphoid hyperplasia: a case report].

Zhonghua zhong liu za zhi [Chinese journal of oncology]
2024

S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma.

JTO clinical and research reports
2024

Clinical application of standardization right thoracic incision for thoracoscopic thymic tumor resection.

Journal of cardiothoracic surgery
2025

Specific Efficacy and Safety in the Clinical Application of Anlotinib for Thymic Carcinoma.

Alternative therapies in health and medicine
2024

A robotic-assisted thymectomy is equivalent to a transsternal resection in large thymomas.

Journal of thoracic disease
2024

Investigating the impact of tumor size on survival outcomes in thymoma and thymic carcinoma patients using the SEER database.

Scientific reports
2025

Localized Unresectable Thymic Carcinoma Treated with Induction Chemotherapy with Lenvatinib before Radiotherapy.

Internal medicine (Tokyo, Japan)
2023

Pleural recurrence 21 years after complete resection of thymic mucoepidermoid carcinoma: a case report.

General thoracic and cardiovascular surgery cases
2024

DNA methylation analysis of multiple genes in thymic epithelial tumors.

Epigenomics
2024

Clinical features and prognostic factors in thymoma and thymic carcinoma.

Indian journal of thoracic and cardiovascular surgery
2024

Thymoma and thymic carcinoma.

Indian journal of thoracic and cardiovascular surgery
2024

Hepatoid thymic carcinoma in a polycythemia vera patient treated with ropeginterferon Alfa-2b: Clinical, histopathological and molecular correlates.

Pathology, research and practice
2024

Association between Infection and Calculated Globulin Level among Patients with Thymic Epithelial Tumor.

Journal of clinical medicine
2024

An extremely rare case of thymic squamous cell carcinoma complicated with B3 thymoma and myasthenia gravis: a case report.

Surgical case reports
2025

TMPRSS2::ETS translocation in nonprostatic malignancies: an unexpected finding in thymic carcinoma and pulmonary adenocarcinoma.

Virchows Archiv : an international journal of pathology
2024

Abnormal Cellular Populations Shape Thymic Epithelial Tumor Heterogeneity and Anti-Tumor by Blocking Metabolic Interactions in Organoids.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024

Postoperative radiotherapy for completely resected thymoma and thymic carcinoma: A systematic review and meta-analysis.

PloS one
2024

Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma.

Lung cancer (Amsterdam, Netherlands)
2024

ACTN4 is associated with the malignant potential of thymic epithelial tumors through the β-catenin/Slug pathway.

Cancer science
2024

Postoperative radiotherapy for thymic epithelial tumors: a narrative review.

Mediastinum (Hong Kong, China)
2024

Narrative review of indication and management of induction therapy for thymic epithelial tumors.

Mediastinum (Hong Kong, China)
2024

Re-evaluation and operative indications after induction therapy for thymic epithelial tumors.

Mediastinum (Hong Kong, China)
Ver todos os 921 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Carcinoma tímico.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Carcinoma tímico

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins.
    JAMA network open· 2026· PMID 41848733mais citado
  2. Neuro-ophthalmic presentation of leptomeningeal metastasis of thymoma: a case report.
    Frontiers in neurology· 2026· PMID 41821629mais citado
  3. Thymic carcinoma presenting with cardiac tamponade and superior vena cava invasion.
    BMJ case reports· 2026· PMID 41494701mais citado
  4. Transforming Growth Factor-&#x3b2;1 as a Biomarker of Malignant Behavior and PD-L1 Expression in Thymic Epithelial Tumors.
    Cancer science· 2026· PMID 41204788mais citado
  5. Case Report of a Rare Pediatric B2 Thymoma With Focal Thymic Carcinoma Foci and Bone Marrow Metastasis.
    Pediatric blood &amp; cancer· 2026· PMID 41873200mais citado
  6. Prognostic value as metabolic tumor activity on (18)F-FDG uptake in thymic epithelial tumors.
    J Thorac Dis· 2026· PMID 41988293recente
  7. Surgical Management of Primary and Metastatic Cardiac Malignancies: A 20-Year Single-Center Experience.
    Ann Thorac Cardiovasc Surg· 2026· PMID 41987379recente
  8. HER2 expression and HER2 gene amplification in thymic epithelial tumors: a narrative review.
    Mediastinum· 2026· PMID 41982620recente
  9. Management of liver metastases secondary to thymic epithelial tumors: a narrative review of current management and future directions.
    Mediastinum· 2026· PMID 41982619recente
  10. Reframing thymic epithelial tumors through single-cell transcriptomics: a narrative review.
    Mediastinum· 2026· PMID 41982618recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:99868(Orphanet)
  2. MONDO:0006451(MONDO)
  3. GARD:19695(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q7799620(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Carcinoma tímico
Compêndio · Raras BR

Carcinoma tímico

ORPHA:99868 · MONDO:0006451
Prevalência
Unknown
Herança
Not applicable
CID-10
C37 · Neoplasia maligna do timo
CID-11
Ensaios
22 ativos
Início
Adult
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0205969
EuropePMC
Wikidata
Papers 10a
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades